Intratumoral heterogeneity in PD-L1 expression in pleomorphic lung carcinoma: implications for management of stage III disease. (January 2019) - Januszewski, A.; Chang, W.; Zhang, Y.Z.; Laggner, U.; Bowman, A.; Adefila-Ideozu, T.; Moffatt, M.; Cookson, W.; Nicholson, A.G.; Popat, S.; Bowcock, A.